In a large cohort of clinical NPC tissues high expression of ARHGEF3 was positively associated with an increased T status, distant metastasis, and a more advanced clinical stage (P < 0.05). The gene discussed is ARHGEF3; the disease is nasopharyngeal carcinoma.